Case Studies / fCAL turbo

CALEX-Sample-Preparation
Switching from Phadia to BÜHLMANN for a More Efficient Calprotectin Service

The Newcastle upon Tyne Hospitals Foundation Trust is one of the largest NHS trusts in the UK, covering six hospitals. Elodie and her team in the department of blood sciences

A. Suter
Using the BÜHLMANN fCAL® turbo on Beckman Coulter AU5800 – A Report from SYNLAB

A Report of A. Suter* and Dr. C. Fuhrer** from SYNLAB *BMA HF/ Fachleiterin, **Head of Core Lab, FAMH Clinical Chemistry, NF hematology, microbiology and immunology; SYNLAB Suisse SA, Alpenquai

Martina-Kobelt
Experience of the BÜHLMANN fCAL® turbo on DxC 800, Beckman Coulter

A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin, KS St. Gallen, Switzerland *Senior Laboratory Technician Core Lab, **Deputy Head of Department Core Lab/FAMH Candidate Clinical Chemistry, Centre

Unilabs Portugal using BÜHLMANN fCAL® turbo in routine

Unilabs Portugal, a private European lab chain, made a comprehensive evaluation of different Calprotectin assays on the market. Finally, they choose the BÜHLMANN fCAL® turbo simply because it is faster,

From BÜHLMANN Quantum Blue® to fCAL turbo®

Follow the Evolution of Calprotectin Testing at James Cook University Hospital This interview with Mr Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough, discusses recent changes made to the faecal calprotectin testing

Table1_Calprotectin-and-Clinical-Correlation
Calprotectin and Clinical Correlation

Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork In issue 2017-3 of Leading Edge, Mary O’Connell detailed her evaluation of the BÜHLMANN fCAL® turbo assay on the Abbott Architect C8000 analyser in comparison

fCAL turbo vs. IBDoc
Calprotectin Home vs. Laboratory Test

Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork, Ireland The Mercy University hospital is one of the largest users of the IBDoc test, with almost 500 patients using the system to

Mary OConnell
Bringing Calprotectin Testing In-house on the Abbott Architect C8000

Mary O’Connell née Deasy, Biochemistry Department Mercy University Hospital Cork, Ireland describes her experience introducing the BÜHLMANN fCAL turbo assay onto her department’s Abbott Architect C8000. At the Biochemistry Department

Rosie Forster, Queen Elizabeth Hospital Birmingham, with the CALEX and Roche cobas c702
Introducing in-house Calprotectin Testing Directly on the Roche cobas® c702

Turbo Charged from the Start Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN fCAL® turbo assay. Faecal

Anita-Grunauer evaluates fCAL turbo on Roche c501
City Hospital Triemli Optimizes Laboratory Workflow For Calprotectin Testing

Interview with Anita Grünauer (BMA), Dr. Jasmin Barman-Aksözen (Head of Department Chemistry), and Predrag Nesic (Head of Department BMA Chemistry), Institute for Laboratory Medicine, City Hospital Triemli, Zurich …the BÜHLMANN